CN1181089C - 黄姜素的制备方法和含有该成分的口服药物 - Google Patents
黄姜素的制备方法和含有该成分的口服药物 Download PDFInfo
- Publication number
- CN1181089C CN1181089C CNB031080367A CN03108036A CN1181089C CN 1181089 C CN1181089 C CN 1181089C CN B031080367 A CNB031080367 A CN B031080367A CN 03108036 A CN03108036 A CN 03108036A CN 1181089 C CN1181089 C CN 1181089C
- Authority
- CN
- China
- Prior art keywords
- yellow ginger
- saponin
- weight ratio
- weight
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- QRMPRVXWPCLVNI-YYFQZIEXSA-N Curcumol Chemical compound C1C(=C)[C@@H]2CC[C@H](C)[C@@]22C[C@@H](C(C)C)[C@]1(O)O2 QRMPRVXWPCLVNI-YYFQZIEXSA-N 0.000 title 4
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 title 2
- 244000062245 Hedychium flavescens Species 0.000 claims abstract description 94
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 90
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000007788 liquid Substances 0.000 claims abstract description 20
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 7
- 239000007787 solid Substances 0.000 claims abstract description 6
- 239000011347 resin Substances 0.000 claims abstract description 5
- 229920005989 resin Polymers 0.000 claims abstract description 5
- 238000005406 washing Methods 0.000 claims abstract description 5
- 238000010828 elution Methods 0.000 claims abstract description 3
- 239000002775 capsule Substances 0.000 claims description 33
- 229930002600 steroidal saponin Natural products 0.000 claims description 24
- 238000005516 engineering process Methods 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 14
- 238000009472 formulation Methods 0.000 claims description 12
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- 239000007909 solid dosage form Substances 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 2
- 229930182490 saponin Natural products 0.000 abstract description 7
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract description 6
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 239000000284 extract Substances 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 3
- -1 yellow ginger saponin Chemical class 0.000 abstract 4
- 239000012439 solid excipient Substances 0.000 abstract 2
- 150000005856 steroid saponins Chemical class 0.000 abstract 2
- 239000003480 eluent Substances 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 46
- 241000699666 Mus <mouse, genus> Species 0.000 description 28
- 239000001913 cellulose Substances 0.000 description 28
- 229920002678 cellulose Polymers 0.000 description 28
- 238000012360 testing method Methods 0.000 description 19
- 241000282472 Canis lupus familiaris Species 0.000 description 16
- 239000002504 physiological saline solution Substances 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 230000029058 respiratory gaseous exchange Effects 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 12
- 230000001939 inductive effect Effects 0.000 description 11
- 239000002994 raw material Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 230000037396 body weight Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 4
- 238000011047 acute toxicity test Methods 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 230000035487 diastolic blood pressure Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000036387 respiratory rate Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 230000035488 systolic blood pressure Effects 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000002183 duodenal effect Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 238000009495 sugar coating Methods 0.000 description 3
- 206010003084 Areflexia Diseases 0.000 description 2
- 206010011703 Cyanosis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000009465 diaoxinxuekang Substances 0.000 description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 239000009335 naoxintong Substances 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 230000035485 pulse pressure Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 101800004637 Communis Proteins 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000009926 Dioscorea panthaica Nutrition 0.000 description 1
- 241000374766 Dioscorea panthaica Species 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000008899 fufang danshen Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 206010030899 opisthotonus Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000005622 photoelectricity Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000000718 qrs complex Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 239000011122 softwood Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031080367A CN1181089C (zh) | 2003-05-19 | 2003-05-19 | 黄姜素的制备方法和含有该成分的口服药物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031080367A CN1181089C (zh) | 2003-05-19 | 2003-05-19 | 黄姜素的制备方法和含有该成分的口服药物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1453290A CN1453290A (zh) | 2003-11-05 |
CN1181089C true CN1181089C (zh) | 2004-12-22 |
Family
ID=29259883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031080367A Expired - Fee Related CN1181089C (zh) | 2003-05-19 | 2003-05-19 | 黄姜素的制备方法和含有该成分的口服药物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1181089C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102451333B (zh) * | 2010-10-20 | 2014-02-05 | 刘光东 | 一种从黄姜中提取水溶性皂甙的方法 |
-
2003
- 2003-05-19 CN CNB031080367A patent/CN1181089C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1453290A (zh) | 2003-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1762967A (zh) | 甘草次酸衍生物、制备方法及其用途 | |
CN1132615C (zh) | 具有调节血糖功效的保健品及其制备方法 | |
CN1901926A (zh) | 含有葫芦科植物提取物或者从其中分离的具有抗脂肪形成和抗肥胖症活性的纯化提取物的组合物 | |
CN1698709A (zh) | 一种复方黄芩制剂 | |
CN1593583A (zh) | 治疗骨折的复方制剂及其制备方法 | |
CN101041019A (zh) | 一种治疗冠心病的中药组合物及其制备方法 | |
CN1181089C (zh) | 黄姜素的制备方法和含有该成分的口服药物 | |
CN1201805C (zh) | 一种用于放化疗减毒增效的药物组合物及其制备方法 | |
CN1586533A (zh) | 一种扶正固本、健脾益肾,宁心安神,活血化淤的组合物 | |
CN1596939A (zh) | 一种治疗心脑血管疾病的中成药及其制备方法 | |
CN1112439A (zh) | 治疗糖尿病的中药及其生产方法 | |
CN100349595C (zh) | 一种通便的药物组合物 | |
CN1879706A (zh) | 双黄连分散片及其制备方法 | |
CN1923270A (zh) | 治疗良性***增生症的药物及其制备方法 | |
CN101049293A (zh) | 乙酰半胱氨酸或其药用盐和细辛脑的药物组合物 | |
CN1296080C (zh) | 清肝降压胶囊及其制备方法 | |
CN1650996A (zh) | 一种药物组合物及其制备方法和应用 | |
CN1911307A (zh) | 一种治疗术后胃肠疾病的药物 | |
CN1730083A (zh) | 元合片及其制备方法 | |
CN1256081C (zh) | 鸦胆子油乳注射液的制备方法 | |
CN1565530A (zh) | 一种治疗尿失禁的药物及其制备方法 | |
CN1089092C (zh) | 一种促分化抑增殖抗癌药二萜类化合物及其制备方法和用途 | |
CN1554407A (zh) | 一种清肺化痰止咳平喘的药物及其制备方法 | |
CN1634496A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN1287835C (zh) | 一种治疗冠心病、心绞痛的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANXI XIDA SCIENCE & TECHNOLOGY PARK DEVELOPMENT Free format text: FORMER OWNER: SUN WENJI Effective date: 20071214 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20071214 Address after: 338 mailbox, Northwestern University, 229 Taibai North Road, Xi'an, Shaanxi Patentee after: Shaanxi west science and Technology Park Development Co., Ltd. Address before: No. 513, Yonghe building, No. 91 Youyi West Road, Shaanxi, Xi'an Patentee before: Sun Wenji |
|
ASS | Succession or assignment of patent right |
Owner name: YANGZIJIANG PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER OWNER: SHANXI XIDA SCIENCE + TECHNOLOGY PARK DEVELOPMENT CO., LTD. Effective date: 20091218 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20091218 Address after: No. 1 Jiangnan Road Jiangnan high port district Jiangsu city Taizhou Province China Patentee after: Yangtze River Pharmaceutical Co., Ltd. Address before: 338 mailbox, Northwestern University, 229 Taibai North Road, Xi'an, Shaanxi Patentee before: Shaanxi west science and Technology Park Development Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190202 Address after: 710069 No. 1405, Block B, Maple Leaf Square, 63 Gaoxin Road, Xi'an High-tech Zone, Shaanxi Province Patentee after: Shaanxi west science and Technology Park Development Co., Ltd. Address before: 225321 Yangzi Jiangnan Road 1, Gao Gang District, Taizhou, Jiangsu Patentee before: Yangtze River Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041222 Termination date: 20190519 |